Literature DB >> 25066631

Robust expansion of dendritic cells in vivo by hydrodynamic FLT3L-FC gene transfer.

Hua Tu1, Thomas M Burke2, Cecilia Oderup2, Kexin Huang1, Kathryn Wong2, Susanna Lewén2, Melissa LaJevic3, Brian A Zabel4.   

Abstract

Due to low numbers of endogenous dendritic cells (DCs) in vivo, exogenous DC-poietin Fms-like tyrosine kinase 3-ligand (FLT3L) is routinely used to generate DC for subsequent studies. We engineered a novel FLT3L-FC DNA construct that, when combined with hydrodynamic gene transfer (HDT), induced robust DC expansion in mice. DC generated in vivo by FLT3L-FC HDT produced cytokines in response to stimulation by an array of TLR agonists and promoted T cell proliferation. The FLT3L-FC protein produced in vivo spontaneously homodimerized to enable effective FLT signaling and the FC-domain enhanced its plasma half-life, providing an improved reagent and method to boost DC numbers.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine; Pharmacodynamics; Pharmacokinetics; Progenitor

Mesh:

Substances:

Year:  2014        PMID: 25066631      PMCID: PMC4253009          DOI: 10.1016/j.jim.2014.07.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

Authors:  G Zhang; V Budker; J A Wolff
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

2.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

Authors:  F Liu; Y Song; D Liu
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

3.  Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.

Authors:  K Brasel; T De Smedt; J L Smith; C R Maliszewski
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

4.  Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.

Authors:  N Mach; S Gillessen; S B Wilson; C Sheehan; M Mihm; G Dranoff
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

5.  Preparation of dendritic cells by in vitro cultures.

Authors:  Mirjana Weimershaus; Peter van Endert
Journal:  Methods Mol Biol       Date:  2013

6.  Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein.

Authors:  George N Cox; Darin J Smith; Sharon J Carlson; Alison M Bendele; Elizabeth A Chlipala; Daniel H Doherty
Journal:  Exp Hematol       Date:  2004-05       Impact factor: 3.084

7.  Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor.

Authors:  C Scheicher; M Mehlig; R Zecher; K Reske
Journal:  J Immunol Methods       Date:  1992-10-02       Impact factor: 2.303

8.  Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.

Authors:  C Hannum; J Culpepper; D Campbell; T McClanahan; S Zurawski; J F Bazan; R Kastelein; S Hudak; J Wagner; J Mattson
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

9.  Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice.

Authors:  S N Robinson; J M Chavez; V M Pisarev; R L Mosley; G J Rosenthal; J M Blonder; J E Talmadge
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

10.  Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo.

Authors:  Holger Karsunky; Miriam Merad; Antonio Cozzio; Irving L Weissman; Markus G Manz
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  3 in total

1.  Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation.

Authors:  Ofer Guttman; Adrien Le Thomas; Scot Marsters; David A Lawrence; Lauren Gutgesell; Iratxe Zuazo-Gaztelu; Jonathan M Harnoss; Simone M Haag; Aditya Murthy; Geraldine Strasser; Zora Modrusan; Thomas Wu; Ira Mellman; Avi Ashkenazi
Journal:  J Cell Biol       Date:  2022-04-21       Impact factor: 8.077

Review 2.  Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp.

Authors:  Rafael Freitas-Silva; Maria Carolina Accioly Brelaz-de-Castro; Antônio Mauro Rezende; Valéria Rêgo Pereira
Journal:  Front Immunol       Date:  2014-11-26       Impact factor: 7.561

3.  A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models.

Authors:  Nicole Salazar; Jeffrey C Carlson; Kexin Huang; Yayue Zheng; Cecilia Oderup; Julia Gross; Andrew D Jang; Thomas M Burke; Susanna Lewén; Alexander Scholz; Serina Huang; Leona Nease; Jon Kosek; Michel Mittelbronn; Eugene C Butcher; Hua Tu; Brian A Zabel
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.